Topics:

Osteoarthritis

A Glimpse Into the Future of Rheumatology

David Pisetsky MD, new President-elect of the US Bone and Joint Initiative, is likely to be influential  in defining the path of rheumatology in coming years. Listen here as he speaks about the role of rheumatologists in a patient-centered, multidisciplinary medical future.

Osteoarthritis

David Pisetsky MD

(AUDIO) David Pisetsky MD, new President-elect of the US Bone and Joint Initiative, offers his perspective.on the role of rheumatologists in a patient-centered, multidisciplinary medical future.

Are your patients with knee osteoarthritis quietly avoiding exercise, fearing it will worsen their pain? A new randomized trial shows they are mistaken: It eases pain. Another trial shows how much walking helps -- literally how much.

knee OA

Proposing a four-step plan to prioritize management strategies for symptomatic knee OA, from supplements to surgery, a European expert body endorses intra-articular hyaluronic acid and glucosamine.

The US Food and Drug Administration has approved generic forms of the nonsteroidal anti-inflammatory drug celecoxib, used for rheumatoid arthritis and osteoarthritis as well as acute pain.

For the success of total hip replacements, 35 is the magic number, a very large Canadian study finds. Procedures done by surgeons with lower volumes per year have much greater failure risks.

What are the most important outcomes for patients with foot, ankle, knee or hip OA? Turns out, research on OA treatment has not addressed these patient concerns: there is little research about patients’ own preferences.

One observational study links quite modest regular physical activity with striking reductions in the risk of disability from knee osteoarthritis. Another suggests three simple, effective tests for physical function.

Pages

Subscribe to Osteoarthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.